Tilvis Reijo S, Kähönen-Väre Mervi H, Jolkkonen Juha, Valvanne Jaakko, Pitkala Kaisu H, Strandberg Timo E
Geriatric Clinic, Department of Medicine, Helsinki University Central Hospital, Finland.
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):268-74. doi: 10.1093/gerona/59.3.m268.
The search for preventable and remediable risk conditions of cognitive decline is ongoing, but results have thus far been inconsistent. According to the hypothesis of our 10-year prospective study, the predictive values of different risk indicators change over time in a general 75+ population.
A population-based sample of 75-, 80-, and 85-year-old individuals (n=650) underwent comprehensive clinical examinations in 1990 in Helsinki, Finland. Cognitive function was assessed by the Mini-Mental State Examination (MMSE) and/or Clinical Dementia Rating (CDR) at baseline and after 1, 5, and 10 years.
At baseline, a low MMSE score was associated with age, history of stroke, apolipoprotein E allele epsilon4 (APOE4), and intermittent claudication. After 1 year, cognitive decline was typical of participants suffering from vascular diseases, e.g., heart failure and intermittent claudication. Five-year decline was predicted by the presence of atrial fibrillation (RR [relative risk] 2.8), APOE4 (RR 2.4), elevated C-reactive protein (CRP) (RR 2.3), diabetes mellitus (RR 2.2), and heart failure (RR 1.8). They also tended to increase 5-year all-cause mortality. At 10 years, the decline associated with APOE4 (RR 3.3), slightly elevated serum ionized calcium (RR 3.3), and feelings of loneliness (RR 3.0).
Long follow-up of a general aged population explains several inconsistencies of earlier reports. In 75+ individuals, general ill health is a strong associate of cognitive deficits. The strongest predictors of both cognitive decline and mortality are age, APOE4, manifest vascular diseases, and diabetes. The role of new potential predictors, feelings of loneliness and hypercalcemia, needs clinical testing.
对认知功能衰退可预防和可补救风险因素的探索仍在继续,但目前结果并不一致。根据我们10年前瞻性研究的假设,在75岁及以上的普通人群中,不同风险指标的预测价值会随时间变化。
1990年,在芬兰赫尔辛基,对75岁、80岁和85岁的人群(n = 650)进行了基于人群的抽样,并进行了全面的临床检查。在基线以及1年、5年和10年后,通过简易精神状态检查表(MMSE)和/或临床痴呆评定量表(CDR)评估认知功能。
在基线时,MMSE得分低与年龄、中风史、载脂蛋白Eε4等位基因(APOE4)和间歇性跛行有关。1年后,认知功能衰退在患有血管疾病(如心力衰竭和间歇性跛行)的参与者中较为典型。房颤(相对风险[RR]2.8)、APOE4(RR 2.4)、C反应蛋白(CRP)升高(RR 2.3)、糖尿病(RR 2.2)和心力衰竭(RR 1.8)可预测5年的认知功能衰退。它们还往往会增加5年全因死亡率。在10年时,认知功能衰退与APOE4(RR 3.3)、血清离子钙略有升高(RR 3.3)和孤独感(RR 3.0)有关。
对普通老年人群的长期随访解释了早期报告中的一些不一致之处。在75岁及以上的个体中,总体健康状况不佳与认知缺陷密切相关。认知功能衰退和死亡率的最强预测因素是年龄、APOE4、明显的血管疾病和糖尿病。新的潜在预测因素孤独感和高钙血症的作用需要进行临床检验。